About: Association of hormone replacement therapy with hemostatic and other cardiovascular risk factors. The FINRISK Hemostasis Study

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Association of hormone replacement therapy with hemostatic and other cardiovascular risk factors. The FINRISK Hemostasis Study Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 01 October 1995

Attributes	Values
rdf:type	Item
description	wetenschappelijk artikel (nl) наукова стаття, опублікована в жовтні 1995 (uk) article scientifique publié en 1995 (fr) im Oktober 1995 veröffentlichter wissenschaftlicher Artikel (de) artículu científicu espublizáu n'ochobre de 1995 (ast) scientific article published on 01 October 1995 (en)
publication date	wds:Q71799117-67FC73B7-22C6-48A5-B79E-495FAC291BB6
publication date	1995-10-01 00:00:00Z (xsd:dateTime)
author name string	wds:Q71799117-2B527776-37C5-4D26-B5C6-4381ABD1B2A5 wds:Q71799117-54A31337-99D3-4C56-BEDA-F06FABAC7CF4 wds:Q71799117-85A73895-E9E8-42CA-9242-610864F2AFBE wds:Q71799117-9F2EF7B6-62A5-4138-AC7F-686952A76656 wds:Q71799117-C2B56A4F-EEB7-451D-A90B-2611D807A614 wds:Q71799117-D1FEAEA3-178B-4FFE-9001-92627D7BFEBE wds:Q71799117-E9D1B3FF-A17C-4613-851C-3AD5ED17F94D
author name string	M Jauhiainen C Ehnholm E Vahtera V Rasi V Salomaa E Vartiainen G Myllylä
rdfs:label	Association of hormone replacement therapy with hemostatic and other cardiovascular risk factors. The FINRISK Hemostasis Study (en) Association of hormone replacement therapy with hemostatic and other cardiovascular risk factors. The FINRISK Hemostasis Study (nl)
skos:prefLabel	Association of hormone replacement therapy with hemostatic and other cardiovascular risk factors. The FINRISK Hemostasis Study (en) Association of hormone replacement therapy with hemostatic and other cardiovascular risk factors. The FINRISK Hemostasis Study (nl)
name	Association of hormone replacement therapy with hemostatic and other cardiovascular risk factors. The FINRISK Hemostasis Study (en) Association of hormone replacement therapy with hemostatic and other cardiovascular risk factors. The FINRISK Hemostasis Study (nl)
author	wds:Q71799117-6D612BBF-48D0-4DC6-B6D1-EBA6302D5B08 wds:Q71799117-6F983159-FC17-43A9-8ADF-5E6A75089481
author	Jaakko Tuomilehto Juha R. Pekkanen
title	wds:Q71799117-5ECF4EF6-DE92-44C8-A17D-D422AB7C5FB9
title	Association of hormone replacement therapy with hemostatic and other cardiovascular risk factors. The FINRISK Hemostasis Study (en)
page(s)	wds:Q71799117-E7A8B3D7-6FD4-45AD-98A6-AF964C02D3F7
page(s)	1549-1555
instance of	wds:Q71799117-91E366B9-ADDF-450B-97F5-194EB30DA3E0
instance of	scholarly article
main subject	wds:Q71799117-CAA2489B-B3A0-433C-9484-92715A05E0F7
main subject	Hormone Replacement Therapy
PubMed ID	wds:Q71799117-EA8AF45A-EBE1-4F01-B7BA-6DECAD89322B
PubMed ID	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/7583526
PubMed ID	7583526
published in	wds:Q71799117-787DF456-E2EF-436E-B0A1-743BCBDF44A7
published in	Arteriosclerosis, Thrombosis, and Vascular Biology
issue	wds:Q71799117-E0CFF714-F205-4F3F-9C8C-4B47EFD6A82F
volume	wds:Q71799117-3E42E342-A74C-4542-A85D-8E6E5FF1206A
issue	10
volume	15
DOI	wds:Q71799117-C28D439C-5B28-47FC-88E6-45D0EF90A2AB
DOI	http://dx.doi.org/10.1161/01.ATV.15.10.1549
DOI	10.1161/01.ATV.15.10.1549
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q71799117
is cites work of	Hormone replacement therapy and risk of non-fatal stroke The effect of 17beta-estradiol on endothelial and inflammatory markers in postmenopausal women: a randomized, controlled trial Long-term effects of combined hormone replacement therapy on markers of endothelial function and inflammatory activity in healthy postmenopausal women Effects of hormone replacement therapy on hemostatic cardiovascular risk factors The effects of hormone replacement therapy on coronary heart disease Effect of long-term hormone replacement therapy on tissue factor pathway inhibitor and thrombin activatable fibrinolysis inhibitor in healthy postmenopausal women: a randomized controlled study Hormone replacement therapy and body size: how much does lifestyle explain? Hormone replacement therapy, C-reactive protein, and fibrinogen in healthy postmenopausal women National differences in lipid response to postmenopausal hormone replacement therapy The relationship between the female menopause and serum sialic acid, a known cardiovascular risk factor Inhibition of LDL oxidation by a new estradiol receptor modulator compound LY-139478, comparative effect with other steroids
is cites work of	wds:Q59057086-5166AF12-4704-4F1F-B61E-E0F20AE7311B wds:Q44111500-E434B132-6F89-4C65-9A99-B61203D37556 wds:Q74445959-8B3175B2-245B-4DE9-8229-EE9623E5C4F5 wds:Q41507873-D4415EA5-B0B1-4C1B-941B-9BAA364F1C70 wds:Q44205516-05785861-3B44-4184-9145-4EC5CE36A942 wds:Q47295458-ED19D2A0-F13F-4A29-92F4-958907920983 wds:Q77323458-67DB827A-4052-4BA5-80E8-1BC83DC24C97 wds:Q44660785-EFE7A39E-3CF8-4E0A-B05C-175F0E8C78F4 wds:Q73846543-4500F065-C9BC-4346-AB1E-B349FF6C4346 wds:Q74240125-0CEAAC7B-BF53-4FAA-BDC8-B0F99F998B4F wds:Q78168514-ED7C3C60-A908-4243-8A90-57AB9FF829AF

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 171 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software